Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06136221 · ClinicalTrials.gov registry record · NA

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

A NA study of Physical Inactivity and Cirrhosis, Liver, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
2
Study locations

NCT06136221 is a NA study of Physical Inactivity and Cirrhosis, Liver that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 110 participants, below the 223-participant average among 59 other Physical Inactivity trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06136221, a NA study of Physical Inactivity and Cirrhosis, Liver, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
2
Study locations

Study Summary

Remote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investigating whether a remote nutrition, physical activity, and education intervention can improve health outcomes in those with cirrhosis. In this clinical trial, individuals will be randomized to either enhanced usual care or the LiverWatch intervention. Both groups are given fitbits and asked to increase their step counts. Those in the Liverwatch group will be incentivized for increase their physical activity while also undergoing a personalized nutrition intervention and weekly symptom monitoring and cirrhosis education.

Conditions Studied

Physical Inactivity Cirrhosis, Liver End Stage Liver DIsease Muscle Loss Symptoms and Signs

Interventions

  • BEHAVIORAL LiverWatch Intervention

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2024-05-01
Est. Completion 2026-05-31
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06136221

The ClinicalTrials.gov registry entry for NCT06136221 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 223-participant average among 59 other Physical Inactivity trials with a reported enrollment target (51% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Physical Inactivity appearing as the primary indexed condition, and to 1 intervention - of which LiverWatch Intervention is the first listed.

NCT06136221 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06136221 about?

NCT06136221 is a clinical study titled "Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease". Remote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investigating whether a remote nutrition, physical activity, and education intervention can improve health ou...

What is the current status of trial NCT06136221?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2024-05-01. Estimated completion is 2026-05-31.

What conditions does trial NCT06136221 study?

This clinical trial studies the following conditions: Physical Inactivity, Cirrhosis, Liver, End Stage Liver DIsease, Muscle Loss, Symptoms and Signs.

What interventions are being tested in trial NCT06136221?

The interventions under investigation include: LiverWatch Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06136221?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06136221 being conducted?

This trial has 2 study locations across Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Physical Inactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Physical Inactivity

All registered trials for this condition

Cirrhosis, Liver

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.